News Oct 15, 2026 Scientists create designer enzymes that cut specific proteins like molecular scissors Researchers at the University of Washington have computationally designed synthetic proteases - enzymes that precisely cut other proteins at chosen sequences. Two studies published in Nature describe zinc-based metalloproteases and cysteine proteases created entirely from scratch using deep learning. These designer enzymes show rate enhancements millions to hundreds of millions of times faster than uncatalyzed reactions, and they work inside living cells. The work opens paths to destroying disease proteins, clearing misfolded proteins from neurodegenerative diseases, and activating drugs only in targeted tissues. Giulio Prisco 2 min read
News Sep 18, 2026 Software scientists form a virtual drug company and sketch a cancer treatment Artificial intelligence programs reviewed tens of thousands of human drug studies, found a pattern tied to success, and proposed a lung cancer design later taken up by a manufacturer. Giulio Prisco 2 min read
News Oct 6, 2026 Stanford professor Karl Deisseroth wins Nobel Prize for inventing optogenetics Karl Deisseroth, a Stanford professor of bioengineering and psychiatry, has been awarded the 2026 Nobel Prize in physiology or medicine for developing optogenetics, a technique that uses light to control individual nerve cells in the living brain. Giulio Prisco 2 min read
Mindbytes Sep 30, 2026 Phrontline Begins Human Trial of Dual-Payload Cancer Drug TJ102 combines two tumour targets and two drug payloads in an early-stage study that will assess safety and preliminary activity. Linsey Smith 1 min read
Mindbytes Sep 30, 2026 DeepMind Gives AI-Designed Proteins a Hidden Signature Could AI-designed proteins carry a hidden signature? Google DeepMind’s SynthID Bio embeds detectable watermarks that survived laboratory testing while preserving biological activity, opening a path to tracking their origins. gizmo guru 1 min read
News Sep 30, 2026 Anthropic's AI enzyme discovery faces originality questions amid pattern of disputed claims Anthropic announced that its AI model Claude discovered a novel CRISPR-like enzyme system in just 21 hours, a task that might have taken humans months. However, a computational biologist at the University of Copenhagen claims he identified the same proteins a year earlier, raising concerns that this may be part of a broader pattern of disputed AI research claims. Giulio Prisco 2 min read
News Sep 11, 2026 An AI-designed lung drug enters clinical trial after a hint of rejuvenation Rentosertib, built with generative AI for scarred lungs, starts a year-long study after protein clocks suggested treated patients looked biologically younger. Giulio Prisco 2 min read
News Sep 10, 2026 An AI-designed lung drug lowers biological age scores in a small trial Six independent protein-based aging clocks moved younger in forty-two patients with idiopathic pulmonary fibrosis, with the strongest signal at four weeks on a mid-range dose. Giulio Prisco 2 min read
Mindbytes Aug 10, 2026 AI Creates 16 Never-Before-Seen Viruses Scientists used AI to generate 16 viable viruses not found in nature, marking a first that experts say demands urgent safeguards against dual-use risks. Linsey Smith 1 min read
News Sep 1, 2026 Nanoparticles help new neurons form in Alzheimer’s models A polymer nanogel crossed into the brain, lowered one protein in support cells, and produced working neurons plus better memory in mice. Giulio Prisco 2 min read